Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Hemotec, Inc. — Predicate Candidate Screening
15 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
55 daysmedian FDA review time
97 days90th percentile
15clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
| K902081 | CLOTTRAC(TM) IBEX HEPARINASE HR ACT CART./CONTROL | Hemotec, Inc. | 1990-07-03 | 56 | 0 |
| K894359 | CLOTRAC CITRATED WHOLE BLOOD COAGULATION CONTROLS | Hemotec, Inc. | 1989-09-05 | 53 | 0 |
| K894317 | HEMOTEC HEPCON HMS COAGULATION SYSTEM & ACCESS. | Hemotec, Inc. | 1989-09-05 | 53 | 1 |
| K894466 | HEPCON(R) CV WHOLE BLOOD COAGULATION CONTROLS | Hemotec, Inc. | 1989-09-05 | 49 | 0 |
| K884590 | HEPCON/SYSTEM B-10 HEPARIN ASSAY/SCREEN/CARTRIDGES | Hemotec, Inc. | 1989-01-10 | 68 | 0 |
| K875089 | HEPCON SYSTEM B-10 ACTIVATED CLOT TIME & HEPARIN | Hemotec, Inc. | 1988-03-09 | 91 | 0 |
| K880302 | CALCIUM CHLORIDE SOLUTION 0.1M, IN HEPES BUFFER | Hemotec, Inc. | 1988-02-19 | 25 | 0 |
| K854377 | HEMOTEC CV WHOLE BLOOD COAGULATION CONTROLS | Hemotec, Inc. | 1985-12-04 | 35 | 0 |
| K854376 | HEMOTEC CITRATED WHOLE BLOOD COAGULATION CONTROLS | Hemotec, Inc. | 1985-12-04 | 35 | 0 |
| K853789 | ADDITIONAL HEMOTEC HEPCON/SYS B-10 COAGULATION CAR | Hemotec, Inc. | 1985-10-04 | 24 | 0 |
| K843459 | HEMOTEC ACT I SYSTEM | Hemotec, Inc. | 1984-12-12 | 98 | 0 |
| K841021 | HEMOTEC, HEPCON/SYS B-10 HEPARIN/PROTAM | Hemotec, Inc. | 1984-05-25 | 74 | 0 |
| K830665 | HEPCOL SYSTEM B-10 & B-10-P | Hemotec, Inc. | 1983-06-08 | 97 | 0 |
| K820410 | HEMOTEC HEPCON/SYSTEM FOUR & FOUR P | Hemotec, Inc. | 1982-04-09 | 56 | 0 |
| K800161 | HEPCON/SYSTEM RC-10 | Hemotec, Inc. | 1980-03-19 | 55 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda